Resmed Inc

RMD

222.850USD

-1.630-0.73%

Close 04/01, 16:00（ET）Quotes delayed by 15 min

Resmed Inc's Score

Industry at a Glance

Industry Ranking

30 / 208

Overall Ranking

116 / 4532

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Resmed Inc Highlights

StrengthsRisks

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 21.86% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 5.15B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 22.19%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.19%.

Undervalued

The company’s latest PE is 21.94, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 96.95M shares, decreasing 1.47% quarter-over-quarter.

Held by ETHSX

Star Investor ETHSX holds 17.10K shares of this stock.

Analyst Rating

Based on 21 analysts

Buy

Current Rating

296.889

Target Price

+34.93%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Resmed Inc is 9.23, ranking 5 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.42B, representing a year-over-year increase of 10.98%, while its net profit experienced a year-over-year increase of 13.92%.

Score

Industry at a Glance

Previous score

9.23

Change

0



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.90

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.97

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.29

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Resmed Inc is 7.65, ranking 70 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 21.94, which is 95.02% below the recent high of 42.79 and 1.27% above the recent low of 21.67.

Score

Industry at a Glance

Previous score

7.65

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 30/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Resmed Inc is 7.24, ranking 145 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 300.00, with a high of 335.00 and a low of 225.00.

Score

Industry at a Glance

Previous score

7.33

Change

-0.09

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Resmed Inc is 6.67, ranking 121 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 247.90 and the support level at 208.09, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.74

Change

-0.07

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-04-01

The current institutional shareholding score of Resmed Inc is 5.00, ranking 110 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 66.54%, representing a quarter-over-quarter increase of 1.38%. The largest institutional shareholder is The Vanguard, holding a total of 18.81M shares, representing 12.91% of shares outstanding, with 2.75% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

18.97M

+1.56%

BlackRock Institutional Trust Company, N.A.

8.65M

-0.33%

State Street Investment Management (US)

6.55M

-1.01%

Geode Capital Management, L.L.C.

4.25M

+0.87%

Walter Scott & Partners Ltd.

2.82M

-14.32%

Morgan Stanley & Co. LLC

1.02M

-27.18%

BlackRock Asset Management Ireland Limited

1.11M

-1.74%

Northern Trust Investments, Inc.

1.16M

-0.86%

Charles Schwab Investment Management, Inc.

1.07M

+4.57%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Resmed Inc is 8.82, ranking 17 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.93. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Resmed Inc

RMD

7.62 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.51 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.34 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

West Pharmaceutical Services Inc

WST

8.26 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Globus Medical Inc

GMED

8.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.20 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment